Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren Komarow

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Microbiology Spectrum|December 16, 2024
Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trialRitu Banerjee, Abhigya Giri, Lauren Komarow, et al.
Plos One|May 15, 2009
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trialAndrew Zolopa, Janet Andersen, William Powderly, et al.
AIDS (London, England)|May 24, 2013
Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptomsBrian R Wood, Lauren Komarow, Andrew R Zolopa, et al.
AIDS (London, England)|August 15, 2014
Beta-glucan for Pneumocystis pneumonia diagnosis in persons with AIDS: authors' replyBrian R Wood, Lauren Komarow, Andrew R Zolopa, et al.
HIV Clinical Trials|August 22, 2014
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164Philip M Grant, Lauren Komarow, Alejandro Sanchez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trialKathleen Mulligan, Robert A Parker, Lauren Komarow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2007
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384Michael P Dubé, Lauren Komarow, Kathleen Mulligan, et al.
Open Forum Infectious Diseases|February 23, 2024
Carbapenem-resistant <i>Enterobacterales</i> in Children at 18 US Health Care System Study Sites: Clinical and Molecular Epidemiology From a Prospective Multicenter Cohort StudyMatthew Fisher, Lauren Komarow, Jordan Kahn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumoniaPaul E Sax, Lauren Komarow, Malcolm A Finkelman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2015
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and InflammationMichael P Dubé, Lauren Komarow, Carl J Fichtenbaum, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Microbiology Spectrum|December 16, 2024
Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trialRitu Banerjee, Abhigya Giri, Lauren Komarow, et al.
Plos One|May 15, 2009
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trialAndrew Zolopa, Janet Andersen, William Powderly, et al.
AIDS (London, England)|May 24, 2013
Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptomsBrian R Wood, Lauren Komarow, Andrew R Zolopa, et al.
AIDS (London, England)|August 15, 2014
Beta-glucan for Pneumocystis pneumonia diagnosis in persons with AIDS: authors' replyBrian R Wood, Lauren Komarow, Andrew R Zolopa, et al.
HIV Clinical Trials|August 22, 2014
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164Philip M Grant, Lauren Komarow, Alejandro Sanchez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trialKathleen Mulligan, Robert A Parker, Lauren Komarow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2007
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384Michael P Dubé, Lauren Komarow, Kathleen Mulligan, et al.
Open Forum Infectious Diseases|February 23, 2024
Carbapenem-resistant <i>Enterobacterales</i> in Children at 18 US Health Care System Study Sites: Clinical and Molecular Epidemiology From a Prospective Multicenter Cohort StudyMatthew Fisher, Lauren Komarow, Jordan Kahn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumoniaPaul E Sax, Lauren Komarow, Malcolm A Finkelman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2015
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and InflammationMichael P Dubé, Lauren Komarow, Carl J Fichtenbaum, et al.
Pageof 6